Healthcare -
Biotechnology - NASDAQ - US
$ 2.6
-0.763 %
$ 75.1 M
Market Cap
-0.87
P/E
AVTE - DEPRECIATION & AMORTIZATION
Depreciation & Amortization AVTE - Aerovate Therapeutics, Inc.
96 K
LAST VALUE
152.98%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR